Windtree Therapeutics has announced up to $520 million in new funding, with 99% of proceeds earmarked for BNB acquisitions, signaling one of the most aggressive crypto treasury moves by a public biotech company. Biotech Firm Windtree Doubles Down on Crypto With New BNB Plan Windtree Therapeutics (NasdaqCM: WINT) is pivoting aggressively into digital assets, unveiling […]
Credit: Source link
ADVERTISEMENT
